Proactive Biofilm-Based Wound Management

Proactive Biofilm-Based Wound Management

On-Demand Webcast
Faculty

Shaun Carpenter, MD, FAPWCA, CWSP
Chief Executive Officer
MedCentris
Director
Baton Rouge General Center for Advanced Wound and Hyperbaric Medicine
Baton Rouge, Louisiana

Gregory Schultz, PhD
Professor
Department of Obstetrics and Gynecology
Director
Institute of Wound Research
University of Florida
Gainesville, Florida

Intended Learners

This activity is designed for physicians, podiatrists, physical therapists, and nurses involved in the treatment of patients with chronic wounds.

Learning Objectives

After completing this activity, participants should be able to:

  • Examine a proactive biofilm-based wound management (BBWM) strategy aimed at reducing and preventing biofilm re-formation
  • Employ comprehensive, proactive BBWM protocol, including sharp debridement and application of broad-spectrum antimicrobial therapy followed by adjunctive therapy
  • Review components of an ideal antimicrobial technology
  • Explain the science of polyhexamethylene biguanide hydrochloride (PHMB) antimicrobial
Activity Overview

This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form.

After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

Participants who have successfully completed the live version of this activity are not eligible for credit for this enduring material.

Release Date: April 26, 2017

Expiration Date: April 26, 2018

Estimated time to complete: 1.25 hours

There is no fee associated with this activity.

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested (please download here) for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

Accreditation

 In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CME

NACCME designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE

This continuing nursing education activity awards 1.25 contact hours.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.25 contact hours.

 

Continuing Podiatric Education

North American Center for Continuing Medical Education, LCC (NACCME) is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. NACCME has approved this activity for a maximum of 1.25 continuing education contact hours.

Planning Committee

The planning committee comprises Shaun Carpenter, MD, FAPWCA, CWSP, Daniel Federman, MD, FACP, Gregory Schultz, PhD, Susie Seaman, NP; and Tiffney Oliver, Randy Robbin, John Savage and Sydney Turner, NACCME.

Independent clinical reviewer: Daniel Federman, MD, FACP, Professor of Medicine, Yale University School of Medicine, Associate Chief of Medicine, VA Connecticut Healthcare System, West Haven, Connecticut

Nurse planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, CA

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Carpenter: Consultant/Speaker—Organogenesis, Osiris Therapeutics, ManukaMed, Medline Industries, Integra; Ownership/Board Member—Healtec, HealtecRx, MedCentris, MedCentris Specialty Group, TRUE-See, Wound Care Associates

Dr. Schultz: Grant/Research—Cormedix, Medline Industries, Smith & Nephew; Scientific Advisor—Acelity, Biomonde, Hollister Wound Care, Medline Industries, Smith & Nephew; Stock Shareholder—Quick-Med Technologies; Board Member—Quick-Med Technologies

Ms. Seaman: Scientific advisor—Smith & Nephew, Inc., Promotional Speakers’ Bureau—Smith & Nephew, Inc.

Dr. Federman has disclosed no relevant financial relationships with any commercial interests.

Ms. Oliver, Mr. Robbin, Mr. Savage and Ms. Turner have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty have disclosed that no off-label/unapproved uses of drugs and/or devises will be discussed in the presentations.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2017 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Grant Support

Supported by an educational grant from Organogenesis, Inc.